8-K/A XBRL

PRIMARY DOCUMENT

Company: Zivo Bioscience, Inc.
Filed: September 16, 2021
Period of Report: November 11, 2020
Accession Number: 0001654954-21-010151

View Document ↗ View on SEC.gov ↗